Aldeyra Therapeutics, Inc. - Common Stock (NQ:ALDX)

1.730 -0.010 (-0.57%)

Official Closing Price Updated: 4:00 PM EDT, May 7, 2026 Add to My Watchlist

Price and Volume

Volume	646,041
Open	1.730
Bid (Size)	1.670 (1,000)
Ask (Size)	1.840 (10,600)
Prev. Close	1.740
Today's Range	1.685 - 1.746
52wk Range	1.070 - 6.175
Shares Outstanding	58,576,350
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

May 06, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX

May 05, 2026

From Pomerantz LLP

Via GlobeNewswire

Performance

YTD	-63.0%	-63.0%
1 Month	+13.8%	+13.8%
3 Month	-66.0%	-66.0%
6 Month	-64.0%	-64.0%
1 Year	-13.9%	-13.9%

More News

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 05, 2026

From Schall Law

Via GlobeNewswire

ROSEN, THE FIRST FILING FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

May 03, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors with Large Losses to Contact the Firm Regarding Their Rights Before May 29th

May 01, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

May 01, 2026

From Schall Law

Via GlobeNewswire

REMINDER: Aldeyra Therapeutics, Inc. Investors With Significant Losses Must Act By May 29, 2026

April 30, 2026

From Kirby McInerney LLP

Via GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

April 30, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Aldeyra Therapeutics, Inc.

April 29, 2026

From Robbins LLP

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX

April 28, 2026

From Pomerantz LLP

Via GlobeNewswire

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky

April 28, 2026

From Levi & Korsinsky, LLP

Via Business Wire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 28, 2026

From Schall Law

Via GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

April 27, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors with Large Losses to Contact the Firm Regarding Their Rights Before May 29th

April 24, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 24, 2026

From Schall Law

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX

April 21, 2026

From Pomerantz LLP

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 21, 2026

From Schall Law

Via GlobeNewswire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX

April 18, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 17, 2026

From Schall Law

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors to Contact the Firm Regarding Their Rights

April 15, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX

April 14, 2026

From Pomerantz LLP

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 14, 2026

From Schall Law

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 10, 2026

From Schall Law

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines – ALDX

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 07, 2026

From Schall Law

Via GlobeNewswire

Frequently Asked Questions

Is Aldeyra Therapeutics, Inc. - Common Stock publicly traded?

Yes, Aldeyra Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Aldeyra Therapeutics, Inc. - Common Stock trade on?

Aldeyra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock?

The ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock is ALDX on the Nasdaq Stock Market

What is the current price of Aldeyra Therapeutics, Inc. - Common Stock?

The current price of Aldeyra Therapeutics, Inc. - Common Stock is 1.730

When was Aldeyra Therapeutics, Inc. - Common Stock last traded?

The last trade of Aldeyra Therapeutics, Inc. - Common Stock was at 05/07/26 04:00 PM ET

What is the market capitalization of Aldeyra Therapeutics, Inc. - Common Stock?

The market capitalization of Aldeyra Therapeutics, Inc. - Common Stock is 101.34M

How many shares of Aldeyra Therapeutics, Inc. - Common Stock are outstanding?

Aldeyra Therapeutics, Inc. - Common Stock has 101M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.